GCKR and metabolic dysfunction-associated steatotic liver disease: The GCKR rs1260326, substitutes proline to leucine at position 446 of amino acid (P446L), is a genetic risk factor associated with obesity-associated nonalcoholic fatty liver (NAFLD) and type 2 diabetes mellitus (T2DM) in different population [9, 13, 30].